Last reviewed · How we verify

NCT06091553

Comparison of the Efficacy and Safety of Duloxetine Augmented With Gabapentin and Duloxetine Augmented With Amitriptyline vs Duloxetine Alone in Chemotherapy -Induced Neuropathy

Recruiting now Phase 2 Last updated 16 April 2024
What this trial tests

Phase 2 trial testing Duloxetine alone in Neuropathy in Cacer Patien in 160 participants. Currently enrolling.

Timeline
10 October 2023
Primary endpoint
30 September 2024
31 December 2024

Quick facts

Lead sponsorBeni-Suef University
PhasePhase 2
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment160
Start date10 October 2023
Primary completion30 September 2024
Estimated completion31 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 18 to 75, any sex, with Neuropathy in Cacer Patien. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to elucidate the relationship between the Efficacy and Safety of Comparison of the Efficacy and Safety Duloxetine augmented with gabapentin and amitriptyline augmented with Duloxetine vs duloxetine alone in chemotherapy -Induced Neuropathy in cancer patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy and Safety of Duloxetine with Gabapentin or Amitriptyline Versus Duloxetine Monotherapy in Chemotherapy-Induced Peripheral Neuropathy: Randomized Controlled Trial.
    Salah H, Shaaban AH, Abdelrahman MA, Osama H, et al · · 2026 · PMID 42075808 · DOI 10.3390/ph19040553

Verify or expand the search:

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06091553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing